Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
about
MicroRNAs in Nonalcoholic Fatty Liver DiseasemiR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in miceMicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.Distinct but complementary contributions of PPAR isotypes to energy homeostasis.Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.miRNA-21 ablation protects against liver injury and necroptosis in cholestasis.Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease.MicroRNA-7 mediates cross-talk between metabolic signaling pathways in the liver.MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis.Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption.Concurrent miR-21 suppression and FXR activation as a mechanism of improvement in nonalcoholic fatty liver disease.Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver diseaseTargeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model
P2860
Q26774294-26DCACFC-BD0E-4EE4-A583-B77EFB5710A0Q33815927-9FE217A8-EB53-4B98-BF49-40D2E51AA277Q37607478-8AE97C34-D8DE-45AF-AA9F-2588581D196FQ39214885-2B67B033-9C26-4787-BA83-BF11E949BEDCQ47104903-EBCB7C6E-2D6B-4BEC-B407-73E7D7BC5A7EQ47304510-45F2474E-26DB-4EC3-9583-C7AD985CC752Q48189776-E3F4271F-4907-40E3-825D-4EE6A033CAC1Q48267205-DC3FFE25-3237-4CF9-83CC-17484A357B9EQ49620885-BB0F2DFD-9392-425A-B2C5-F12A93FF8B4EQ52664090-2DD0D3D2-FF92-4363-BCF1-38EF9C91EBC5Q53094807-DA5A1ACD-2979-4847-9D0D-EB920B3B0DC0Q55096281-92D02980-AC7F-4774-AAEE-188CFB7CDA17Q57067876-2EAF30E3-FC28-4770-9EC5-E8B315DE7AD4Q57132035-59CA3471-EF22-49CB-A98E-F6DAD4BE0CAD
P2860
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 September 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liver microRNA-21 is overexpre ...... y inhibiting PPARα expression.
@en
Liver microRNA-21 is overexpre ...... y inhibiting PPARα expression.
@nl
type
label
Liver microRNA-21 is overexpre ...... y inhibiting PPARα expression.
@en
Liver microRNA-21 is overexpre ...... y inhibiting PPARα expression.
@nl
prefLabel
Liver microRNA-21 is overexpre ...... y inhibiting PPARα expression.
@en
Liver microRNA-21 is overexpre ...... y inhibiting PPARα expression.
@nl
P2093
P2860
P50
P921
P1433
P1476
Liver microRNA-21 is overexpre ...... y inhibiting PPARα expression.
@en
P2093
Carina Prip-Buus
Carole Hénique
Coralie L Guerin
Cécile Devue
François Durand
Jérémy Scetbun
Marc E Rothenberg
Nathalie Colnot
Patrick Marcellin
Pierre-Emmanuel Rautou
P2860
P304
P356
10.1136/GUTJNL-2014-308883
P407
P50
P577
2015-09-03T00:00:00Z